Paul Varley

1.7k total citations
31 papers, 923 citations indexed

About

Paul Varley is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cultural Studies. According to data from OpenAlex, Paul Varley has authored 31 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cultural Studies. Recurrent topics in Paul Varley's work include Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Paul Varley is often cited by papers focused on Protein purification and stability (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Paul Varley collaborates with scholars based in United Kingdom, Sweden and United States. Paul Varley's co-authors include Roger H. Pain, G. Marius Clore, Angela M. Gronenborn, Paul T. Wingfield, Henriette Christensen, Sandrine Mulot, Brendan Fish, Yanling Lü, Stephen E. Harding and Johan Rockberg and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Paul Varley

30 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Varley United Kingdom 14 624 174 154 83 81 31 923
Stuart E. Builder United States 17 619 1.0× 133 0.8× 120 0.8× 92 1.1× 26 0.3× 26 1.1k
Judith Senior United Kingdom 12 842 1.3× 72 0.4× 147 1.0× 55 0.7× 122 1.5× 16 1.3k
Kazunori Toma Japan 21 698 1.1× 104 0.6× 165 1.1× 19 0.2× 59 0.7× 64 1.2k
Ritu Mishra Germany 15 645 1.0× 124 0.7× 67 0.4× 57 0.7× 113 1.4× 44 1.0k
Maureen Brennan United States 13 1.1k 1.8× 369 2.1× 216 1.4× 40 0.5× 173 2.1× 21 1.5k
Andrea Caporale Italy 19 656 1.1× 63 0.4× 116 0.8× 128 1.5× 147 1.8× 65 1.0k
Helen Loughrey Ireland 15 473 0.8× 41 0.2× 90 0.6× 43 0.5× 99 1.2× 22 813
Ulrich Rothe Germany 19 627 1.0× 105 0.6× 88 0.6× 26 0.3× 43 0.5× 47 1.1k
Simona Jevševar Slovenia 11 699 1.1× 68 0.4× 244 1.6× 22 0.3× 103 1.3× 15 1.1k
Petri Saviranta Finland 19 877 1.4× 92 0.5× 351 2.3× 20 0.2× 63 0.8× 38 1.1k

Countries citing papers authored by Paul Varley

Since Specialization
Citations

This map shows the geographic impact of Paul Varley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Varley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Varley more than expected).

Fields of papers citing papers by Paul Varley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Varley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Varley. The network helps show where Paul Varley may publish in the future.

Co-authorship network of co-authors of Paul Varley

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Varley. A scholar is included among the top collaborators of Paul Varley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Varley. Paul Varley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malm, Magdalena, Chih‐Chung Kuo, Anna-Luisa Volk, et al.. (2022). Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins. Metabolic Engineering. 72. 171–187. 25 indexed citations
2.
Malm, Magdalena, Magnus Lundqvist, Marco Giudici, et al.. (2021). Author Correction: Evolution from adherent to suspension: systems biology of HEK293 cell line development. Scientific Reports. 11(1). 5407–5407. 4 indexed citations
3.
Malm, Magdalena, Magnus Lundqvist, Marco Giudici, et al.. (2020). Evolution from adherent to suspension: systems biology of HEK293 cell line development. Scientific Reports. 10(1). 18996–18996. 69 indexed citations
4.
Bidkhori, Gholamreza, Magdalena Malm, Ray Field, et al.. (2020). Low Shear Stress Increases Recombinant Protein Production and High Shear Stress Increases Apoptosis in Human Cells. iScience. 23(11). 101653–101653. 36 indexed citations
5.
Zhang, Ye, Magdalena Malm, Richard Turner, et al.. (2019). Small-scale bioreactor supports high density HEK293 cell perfusion culture for the production of recombinant Erythropoietin. Journal of Biotechnology. 309. 44–52. 47 indexed citations
6.
Ouberaï, Myriam, Ana L. Gomes dos Santos, Shimona Madalli, et al.. (2017). Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly. Nature Communications. 8(1). 1026–1026. 30 indexed citations
7.
Nobbmann, Ulf, Malcolm T. Connah, Brendan Fish, et al.. (2007). Dynamic light scattering as a relative tool for assessing the molecular integrity and stability of monoclonal antibodies. Biotechnology and Genetic Engineering Reviews. 24(1). 117–128. 166 indexed citations
8.
Lü, Yanling, Stephen E. Harding, Arthur J. Rowe, et al.. (2007). The Effect of a Point Mutation on the Stability of IgG4 as Monitored by Analytical Ultracentrifugation. Journal of Pharmaceutical Sciences. 97(2). 960–969. 14 indexed citations
9.
Joniau, Steven, et al.. (2006). POSTOPERATIVE PAIN FOLLOWING COBLATION TONSILLECTOMY: RANDOMIZED CLINICAL TRIAL. ANZ Journal of Surgery. 76(4). 226–229. 61 indexed citations
10.
Lappin, Graham, et al.. (2006). Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein. Journal of Pharmaceutical and Biomedical Analysis. 41(4). 1299–1302. 12 indexed citations
11.
Varley, Paul. (2003). Fluorescence Spectroscopy. PubMed. 22. 203–218. 4 indexed citations
12.
Varley, Paul, et al.. (2003). Screening for glycosylation changes on recombinant human IgG using lectin methods. Biotechnology and Applied Biochemistry. 37(1). 1–7. 12 indexed citations
13.
Gearing, A. J. H., Susan J. Thorpe, Karen Miller, et al.. (2002). Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunology Letters. 81(1). 41–48. 62 indexed citations
14.
Fisher, Julie, et al.. (2000). For the record: Chemical modification of a variant of human MIP‐1α; implications for dimer structure. Protein Science. 9(10). 2047–2053. 9 indexed citations
15.
Varley, Paul, et al.. (1997). A case study and use of sedimentation equilibrium analytical ultracentrifugation as a tool for biopharmaceutical development. European Biophysics Journal. 25(5-6). 437–443. 11 indexed citations
16.
Varley, Paul & Eiko Ikegami. (1995). The Taming of the Samurai: Honorific Individualism and the Making of Modern Japan.. Monumenta Nipponica. 50(4). 560–560. 8 indexed citations
17.
Friday, Karl F. & Paul Varley. (1995). Warriors of Japan, as Portrayed in the War Tales.. Monumenta Nipponica. 50(1). 123–123. 2 indexed citations
18.
Patel, Shilpa, et al.. (1993). Characterization of the quaternary structure and conformational properties of the human stem cell inhibitor protein LD78 in solution. Biochemistry. 32(20). 5466–5471. 13 indexed citations
19.
Dryden, David T. F., Paul Varley, & Roger H. Pain. (1992). A study of the hinge‐bending mechanism of yeast 3‐phosphoglycerate kinase. European Journal of Biochemistry. 208(1). 115–123. 12 indexed citations
20.
Varley, Paul & Roger H. Pain. (1991). Relation between stability, dynamics and enzyme activity in 3-phosphoglycerate kinases from yeast and Thermus thermophilus. Journal of Molecular Biology. 220(2). 531–538. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart E. Builder Breakdown of academic impact, for papers by Judith Senior Breakdown of academic impact, for papers by Kazunori Toma Breakdown of academic impact, for papers by Ritu Mishra Breakdown of academic impact, for papers by Maureen Brennan Breakdown of academic impact, for papers by Andrea Caporale Breakdown of academic impact, for papers by Helen Loughrey Breakdown of academic impact, for papers by Ulrich Rothe Breakdown of academic impact, for papers by Simona Jevševar Breakdown of academic impact, for papers by Petri Saviranta
Rankless by CCL
2026